Janus Henderson Group’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$49.5M	Buy	1,998,875 +279,108	+16%	+$6.65M	0.02%	415
2025 Q4	$40.1M	Buy	1,719,767 +1,147,565	+201%	+$25.6M	0.02%	454
2025 Q3	$11.3M	Sell	572,202 -179,360	-24%	-$3.69M	0.01%	724
2025 Q2	$16.3M	Buy	751,562 +431,733	+135%	+$10.2M	0.01%	609
2025 Q1	$7.9M	Sell	319,829 -156,194	-33%	-$3.52M	﹤0.01%	756
2024 Q4	$9.94M	Buy	476,023 +115,832	+32%	+$2.49M	0.01%	733
2024 Q3	$7.16M	Sell	360,191 -1,815,450	-83%	-$33.7M	﹤0.01%	769
2024 Q2	$33.7M	Sell	2,175,641 -550,747	-20%	-$8.57M	0.02%	467
2024 Q1	$43.4M	Buy	2,726,388 +1,587,794	+139%	+$23.9M	0.02%	418
2023 Q4	$19.1M	Buy	1,138,594 +730,695	+179%	+$9.99M	0.01%	561
2023 Q3	$4.77M	Buy	407,899 +101,392	+33%	+$1.36M	﹤0.01%	832
2023 Q2	$4.12M	Buy	306,507 +263,116	+606%	+$3.79M	﹤0.01%	919
2023 Q1	$720K	Buy	43,391 +23,375	+117%	+$386K	﹤0.01%	1810
2022 Q4	$372K	Sell	20,016 -20,018	-50%	-$308K	﹤0.01%	1866
2022 Q3	$514K	Sell	40,034 -23,430	-37%	-$278K	﹤0.01%	1932
2022 Q2	$445K	Sell	63,464 -60,356	-49%	-$443K	﹤0.01%	1836
2022 Q1	$1.03M	Sell	123,820 -33,727	-21%	-$238K	﹤0.01%	1489
2021 Q4	$1.07M	Buy	157,547 +14,259	+10%	+$93.8K	﹤0.01%	1484
2021 Q3	$759K	Sell	143,288 -26,775	-16%	-$146K	﹤0.01%	1439
2021 Q2	$978K	Buy	+170,063	New	+$878K	﹤0.01%	1330